Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes (Q84373796)

From Wikidata

Jump to navigation Jump to search

scientific article published on 09 June 2010

Language	Label	Description	Also known as
English	Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes	scientific article published on 09 June 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

based on heuristic

inferred from title

author name string

In Sil Choi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

Hye Seung Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

Keun-Wook Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

Haeryoung Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

Ki Hwan Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

Yu Jung Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

Jee Hyun Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

Woo Ho Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

Jong Seok Lee

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

publication date

9 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

991-998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20533001 AND SRC:MED&resulttype=core&format=json

5 February 2020

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of immunoreactivity of thymidylate synthase and dihydropyrimidine dehydrogenase in gastric cancer treated with oral fluoropyrimidine (S-1). Study Group of S-1 for Gastric Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global cancer statistics, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of response to 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical application of immunoreactivity of dihydropyrimidine dehydrogenase (DPD) in gastric scirrhous carcinoma treated with S-1, a new DPD inhibitory fluoropyrimidine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Fanconi anaemia/BRCA pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20533001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84373796&oldid=2221581242"